Study of bb2121 in Multiple Myeloma

Clinical trial NCT02658929 · COMPLETED

Trial details

NCT number: NCT02658929
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2015-12-22
Primary completion: 2019-07-22
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.